SC Novartis judgment is pro-innovation

In this article in today’s Indian Express, I argue that the recent Supreme Court judgment in the Novartis’ case is very much pro-innovation, but tries to weed out marketing gimmicks from patent protection.
This blog has previously dealt with the issue here
Written by
Vinay Sitapati
Join the discussion

This site uses Akismet to reduce spam. Learn how your comment data is processed.